Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls

Obstetrics and Gynecology

Volumn 95, Issue 1, 2000, Pages 134-140

  Neuman, Rosalind J ^a,b,c,d   Huettner, Phyllis C ^a,b,c,d   Li, Lina ^a,b,c,d   Mardis, Elaine R ^a,b,c,d   Duffy, Brian F ^a,b,c,d   Wilson, Richard K ^a,b,c,d   Rader, Janet S ^a,b,c,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Oncology   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ADULT; ALLELE; ARTICLE; CANCER INVASION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILY; FEMALE; GENE FREQUENCY; GENE TRANSFER; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADENOCARCINOMA; ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0033988297     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00501-3     Document Type: Article

References (35)

1. Lowy D.R., Kirnbauer R., Schiller J.T. Genital human papillomavirus infection. Proc Natl Acad Sci. 91:1994;2436-2440.
2. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group . J Natl Cancer Inst. 87:1995;796-802.
3. Ries L.A.G., Kosary C.L., Hankey B.F., Miller B.A., Edwards B.K. SEER cancer statistics review 1973-1995. 1998;National Cancer Institute, Bethesda.
4. Schiffman M.H., Brinton L.A. The epidemiology of cervical carcinogenesis. Cancer. 76:1995;1888-1901.
5. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 102:1997;3-8.
6. Beutner K.R., Tyring S. Human papillomavirus and human disease. Am J Med. 102:1997;9-15.
7. Wank R., Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature. 352:1991;723-725.
8. Wank R., Meulen J., Luande J., Enerhardt H.C., Pawlita M. Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602, *301, *0303 alleles. Lancet. 341:1993;1215.
9. Nawa A., Nishiyama Y., Kobayashi T., Wakahara Y., Okamoto T., Kikkawa F., et al. Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger. Cancer. 75:1995;518-521.
10. Helland A., Borresen A.L., Kristensen G., Ronningen K.S. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix Relationship to human papillomavirus infection and prognosis . Cancer Epidemiol Biomarkers Prev. 3:1994;479-486.
11. Gregoire L., Lawrence D., Kukuruga D., Eisenbrey A.B., Lancaster W.D. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer. 57:1994;504-507.
12. Odunsi K., Terry G., Ho L., Bell J., Cuzick J., Ganesan T.S. Association between HLA DQB1*03 and cervical intra-epithelial neoplasia. Mol Med. 1:1995;161-171.
13. Glew S.S., Duggan-Keen M., Cabrera T., Stern P.L. HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res. 52:1992;4009-4016.
14. Glew S.S., Duggan-Keen M., Ghosh A.K., Ivinson A., Sinnott P., Davidson J., et al. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum Immunol. 37:1993;157-164.
15. Apple R.J., Becker T.M., Wheeler C.M., Erlich H.A. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst. 87:1995;427-436.
16. Helland A., Olsen A.O., Gjoen K., Akselsen H.E., Sauer T., Magnus P., et al. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus-positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype A population-based case-control study of Norwegian women . Int J Cancer. 76:1998;19-24.
17. Falk C.T., Rubinstein P. Haplotype relative risks An easy reliable way to construct a proper control sample for risk calculations . Ann Hum Genet. 51:1987;227-233.
18. Terwilliger J., Ott J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum Hered. 42:1992;337-346.
19. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium The insulin gene region and insulin-dependent diabetes mellitus (IDDM) . Am J Hum Genet. 52:1993;506-516.
20. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science. 265:1994;2037-2048.
21. Terwilliger J. A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet. 56:1995;777-787.
22. Spurkland A., Knutsen I., Markussen G., Vartdal F., Egeland T., Thorsby E. HLA matching of unrelated bone marrow transplant pairs Direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support . Tissue Antigens. 41:1993;155-164.
23. Fernandez-Vina M.A., Falco M., Xiaojiang G., Cerra M., Sun Y., Raimondi E., et al. DqA1*03 subtypes have different associations with DRB1 and DQB1 alleles. Hum Immunol. 39:1994;290-298.
24. Fujinaga Y., Shimada M., Okazawa K., Fukushima M., Kato I., Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol. 72:1991;1039-1044.
25. Rader J.S., Kamarasova T., Huettner P.C., Li L., Li Y., Gerhard D.S. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene. 13:1996;2737-2741.
26. Wank R., Schendel D.J., Thomssen C. HLA antigens and cervical carcinoma. Nature. 356:1992;22-23.
27. Mehal W.Z., Lo Y.M.D., Herrington C.S., Evans M.F., Papadopoulos M.C., Odunsi K., et al. Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. J Clin Pathol. 47:1994;1077-1081.
28. Sastre-Garau X., Loste M.N., Vincent-Salomon A., Favre M., Mouret E., de la Rochefordiere A., et al. Decreased frequency of HLA-DRB1 13 alleles in French women with HPV-positive carcinoma of the cervix. Int J Cancer. 69:1996;159-164.
29. Odunsi K., Terry G., Ho L., Bell J., Cuzick J., Ganesan T.S. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Int J Cancer. 67:1996;595-602.
30. Vandenvelde C., De Foor M., Van Beers D. HLA-DQB1*03 and cervical intraepithelial neoplasia grades I-III. Lancet. 341:1993;442-443.
31. David A.L.M., Taylor G.M., Gokhale D., Aplin J.D., Seif M.W., Tindall V.R. HLA-DQB1*03 and cervical intraepithelial neoplasia type III. Lancet. 340:1992;52.
32. Apple R.J., Erlich H.A., Klitz W., Manos M., Becker T.M., Wheeler C.M. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet. 6:1994;157-162.
33. Sanjeevi C.B., Hjelmstrom P., Hallmans G., Wiklund F., Lenner P., Angstrom T., et al. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer. 68:1996;409-414.
34. Begovich A.B., McClure G.R., Suraj V.C., Helmuth R.C., Fildes N., Bugawan T.L., et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol. 148:1992;249-258.
35. Allen M., Kalantari M., Ylitalo N., Pettersson B., Hagmar B., Scheibenpflug L., et al. HLA DQ-DR haplotype and susceptibility to cervical carcinoma Indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18 . Tissue Antigens. 48:1996;32-37.